Loading...

Micro-X Limited

MX1.AXASX
Healthcare
Medical - Devices
A$0.08
A$0.002(2.67%)

Micro-X Limited (MX1.AX) Financial Performance & Income Statement Overview

Review Micro-X Limited (MX1.AX) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.

Revenue Growth
1.45%
1.45%
Operating Income Growth
20.07%
20.07%
Net Income Growth
9.20%
9.20%
Operating Cash Flow Growth
41.46%
41.46%
Operating Margin
11.42%
11.42%
Gross Margin
42.88%
42.88%
Net Profit Margin
-74.74%
74.74%
ROE
-105.90%
105.90%
ROIC
16.92%
16.92%

Micro-X Limited (MX1.AX) Income Statement & Financial Overview

Access detailed annual and quarterly income data for Micro-X Limited MX1.AX financial performance.

MetricQ4 2024Q2 2024Q4 2023Q2 2023
Revenue$7.03M$8.20M$6.98M$8.03M
Cost of Revenue$3.92M$11.96M$12.24M$9.88M
Gross Profit$3.10M-$3.76M-$5.26M-$1.85M
Gross Profit Ratio$0.44-$0.46-$0.75-$0.23
R&D Expenses$12000.00$0.00$0.00$3.31M
SG&A Expenses$9.84M$3.40M$4.39M$5.23M
Operating Expenses-$4.86M$3.40M$4.39M$5.23M
Total Costs & Expenses-$937000.00$15.35M$16.62M$15.11M
Interest Income$0.00$0.00$131000.00$1000.00
Interest Expense$125000.00$123000.00$131000.00$138000.00
Depreciation & Amortization$383000.00$791000.00$814000.00$775000.00
EBITDA-$8.03M-$6.75M-$9.23M-$6.31M
EBITDA Ratio-$1.14-$0.78-$1.27-$0.79
Operating Income$7.96M-$7.16M-$9.65M-$7.08M
Operating Income Ratio$1.13-$0.87-$1.38-$0.88
Other Income/Expenses (Net)-$16.44M-$506000.00-$528000.00$405000.00
Income Before Tax-$8.47M-$7.66M-$10.18M-$7.22M
Income Before Tax Ratio-$1.21-$0.93-$1.46-$0.90
Income Tax Expense-$6.37M$0.00-$3.33M-$3.31M
Net Income-$2.10M-$7.66M-$6.84M-$3.91M
Net Income Ratio-$0.30-$0.93-$0.98-$0.49
EPS-$0.004-$0.01-$0.01-$0.008
Diluted EPS-$0.004-$0.01-$0.01-$0.008
Weighted Avg Shares Outstanding$537.32M$517.07M$514.37M$477.30M
Weighted Avg Shares Outstanding (Diluted)$537.28M$517.07M$514.37M$477.30M

Over the last four quarters, Micro-X Limited's revenue moved from $8.03M in Q2 2023 to $7.03M in Q4 2024. Operating income in Q4 2024 was $7.96M, with a strong operating margin of 113%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Micro-X Limited remained robust at -$8.03M, reflecting operational efficiency. Net income rose to -$2.10M, with an EPS of -$0.004. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;